ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
Niki M Zacharias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.